VAVictória Galletti dos Santos Arraes

Victória Galletti dos Santos Arraes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Victória Galletti dos Santos Arraes has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalência de infecções em pacientes no primeiro ano após o início do tratamento hemodialítico em um município do oeste catarinense

    by Débora Meneghel, Matheus Ribeiro Bizuti, Lucas Medeiros Lima, Victória Galletti, Guilherme Vinicio Sousa Silva, Angela Mitzi Hayashi Xavier, Érica de Brito Pitilin, Débora Tavares Resende e Silva

    A hemodiálise é o tratamento mais utilizado em pacientes com Doença Renal Crônica. Indivíduos submetidos a essa terapia têm grande tendência a desenvolver infecções devido aos efeitos imunossupressores e comorbidades associadas à doença. O objetivo deste trabalho é identificar a prevalência e os fatores associados aos episódios infecciosos ocorridos no primeiro ano após o início do tratamento hemodialítico. Trata-se de um estudo quantitativo, observacional, descritivo e transversal desenvolvido em uma clínica renal de referência no oeste catarinense. Os prontuários dos pacientes em hemodiálise, de ambos os sexos, foram verificados, independentemente da faixa etária. Foram utilizados os seguintes critérios de inclusão: diagnóstico de Doença Renal Crônica e presença de infecção no primeiro ano de tratamento hemodialítico, de janeiro de 2013 a dezembro de 2018. Participaram do estudo 60 pacientes em tratamento hemodialítico e que tiveram infecções no primeiro ano após o início do tratamento. Destes, 65% eram do sexo masculino e 48,3% tinham entre 60 e 79 anos. O acesso vascular tipo fístula arteriovenosa foi utilizado em 73,6% dos pacientes. As infecções do trato urinário foram as mais frequentes, representando 28,7% dos casos. Em relação aos agentes etiológicos, a bactéria Escherichia coli foi identificada em 34,7% das culturas e Enterobacter em 21,7%. Portanto, a prevalência de infecções no primeiro ano após o início do tratamento hemodialítico é significativa. Entende-se que medidas de vigilância para prevenção de infecções devem ser adotadas e o tratamento precoce deve ser priorizado, a fim de evitar complicações futuras.

  • Open Access

    Auriculoterapia e exercício físico resistido na melhora da qualidade de vida de pacientes em hemodiálise

    by Josiano Guilherme Puhle, Pâmela Letícia Weber, Alessandra Yasmin Hoffmann, Natan Rodrigues de Oliveira, Victória Galletti dos Santos Arraes, Lucas Zannini Medeiros Lima, Ana Carolina Gonçalves Zietz, Guilherme Vinicio de Sousa Silva, Débora Tavares de Resende e Silva

    La pérdida de calidad de vida es un hallazgo común en pacientes con enfermedad renal crónica durante el tratamiento de hemodiálisis y se asocia con el desarrollo de otros procesos patológicos, así como con la progresión de la propia enfermedad. Así, el objetivo del presente estudio fue evaluar el efecto de la auriculoterapia y el ejercicio físico resistido, asociados o no, con terapias no farmacológicas sobre la calidad de vida de pacientes con enfermedad renal crónica sometidos a hemodiálisis. La muestra se dividió en 4 grupos: Grupo Control, Grupo Auriculoterapia, Grupo Ejercicio Físico Resistido, Grupo Auriculoterapia+Ejercicio Físico Resistido. La calidad de vida se analizó mediante la Encuesta breve de 36 ítems (SF-36). Para el análisis estadístico se utilizó la prueba de normalidad de Shapiro-Wilk y la prueba de Dixon para valores atípicos, seguido de la prueba de Willcoxon utilizando el software Statistica® 8.0 (STATSOFT). Los aspectos de calidad de vida mejoraron (p≤0,05) en todos los grupos de intervención, con énfasis en la asociación entre auriculoterapia y ejercicio físico resistido, que tuvo impacto en todos los componentes. La aplicación de tratamientos de auriculoterapia y ejercicio físico resistido en pacientes en hemodiálisis sirvieron como herramientas para incrementar la percepción de calidad de vida, siendo alternativas complementarias al tratamiento convencional y conservador.

  • Physical exercise as a modulator of the purinergic system in the control of sarcopenia in individuals with chronic kidney disease on hemodialysis

    by Débora Tavares de Resende e Silva, Matheus Ribeiro Bizuti, Natan Rodrigues de Oliveira, Lucas Zannini Medeiros Lima, Victória Galletti dos Santos Arraes, Ana Carolina Gonçalves Zietz, Carolina Zin, Guilherme Vinício de Sousa Silva, Josiano Guilherme Puhle, Fabiana Brum Haag

    The word sarcopenia derives from the Greek terms “sarx” for meat and “penia” for loss, thus being used to define reductions in muscle mass, muscle strength, and lower physical performance that compromise, mainly, the elderly population. Its high negative impact on patients’ quality of life encourages the production and publication of new studies that seek to find methods to prevent and reverse cases of loss of muscle mass and strength. Furthermore, the high prevalence of sarcopenia in patients with chronic kidney disease (CKD) is closely related to its pathophysiology, which consists of a state of increased protein catabolism and decreased muscle tissue synthesis. Also considering the inflammatory nature of CKD and sarcopenia, the purinergic system has been an important target of studies, which seek to relate it to the two previous conditions. This system achieves anti-inflammatory action by inhibiting, through adenosine, pro-inflammatory factors such as interleukin-12 (IL-12), tumor necrosis factor alpha (TNF-α), and nitric oxide (NO), as well as by releasing anti-inflammatory substances such as interleukin-10 (IL-10). Simultaneously, the purinergic system presents pro-inflammatory activity, signaled by adenosine triphosphate (ATP), which occurs through the activation of T cells and the release of pro-inflammatory factors such as those mentioned above. Therefore, the ability of this system to act on inflammatory processes can promote positive and negative changes in the clinical aspect of patients with CKD and/or sarcopenia. Furthermore, it appears that there is a correlation between the practice of repeated physical exercise with the clinical improvement and in the quality of life of these patients, presenting a decrease in the levels of C-reactive protein (CRP), NTPDase, and the pro-inflammatory cytokine IL-6, such as increases in IL-10 resulting from modulation of the purinergic system. In this way, the present article seeks to evaluate the effect of physical exercise as a modulator of the purinergic system in the control of sarcopenia in patients with CKD on hemodialysis, in order to trace a relationship that can bring benefits both for biological markers and for quality of life of these patients.


  • Open Access

    Heparin and its contribution to the treatment of COVID-19

    by Tamíres Hillesheim Mittelmann, Juliana Baldissera Dors, Victória Galletti dos Santos Arraes, Graciela Soares Fonseca, Cesar Andres Diaz Arias

    The infection caused by SARS-CoV-2 presents changes in the coagulation processes such as venous thromboembolism (VTE) and disseminated intravascular coagulation (DIC) and it has been shown that this coagulopathy is associated by some means with the mortality. Studies suggest that these anticoagulants reduced the mortality of hospitalized patients. However, the studies for this point are not demonstrative, since they are evaluated as multiple variables and the results obtained are not the answer to experimental designs with controlled variables. In most of the cases, the obtained responses are the result of isolated cases or experimental models that do not differentiate statistical data, probably because of the differences related to the study groups. However, in models adjusted for age and sex, the reduction in mortality was statistically significant in patients who were treated with heparins, even when other variables were added to the model. In view of this, there is no consensus regarding the dose and type of anticoagulant, between different countries and entities, but what is most often cited is the use of low molecular weight heparin (LMWH) in a prophylactic dose for all hospitalized patients with the disease. The use of anticoagulants such as heparins has suggested results applicable to the treatment of coagulopathy caused by COVID-19, which makes the subject important for the centralization and analysis of the results. In order to continue with the construction of knowledge around this theme, the objective of this work was to review the use of heparins in the treatment of COVID-19.